1. Why the Name Change to AlphaAI?

Just a year after its previous name change in August 2024, AlphaNox rebranded itself as AlphaAI. Officially, the reason is ‘management purposes and business diversification,’ but it is interpreted as a strategic move to enter the AI market. AlphaAI aims to leverage MDS Tech’s technology and resources to gain a competitive edge in this field.

2. How Are AlphaAI’s Fundamentals?

AlphaAI recorded a net loss in Q3 2025. However, considering one-time expenses (early redemption of convertible bonds and subsidiary divestiture) and R&D investment, the potential for long-term growth remains. Positive factors include expanding market share in the medical sector and new product development and overseas expansion in the healthcare sector.

3. How Does the Market Perceive AlphaAI?

AlphaAI’s stock price surged immediately after the rebranding announcement. The market seems to reflect expectations for the company’s AI venture. However, sustainable investment value will depend on demonstrating tangible results, not just short-term gains.

  • Stock Price: Short-term surge followed by stagnation/decline. Long-term trend depends on earnings improvement.
  • Exchange Rate, Interest Rate, Raw Materials: Continuous monitoring of external factors is crucial.

4. What Investment Strategy Should Investors Consider?

Investing in AlphaAI hinges on the success of its AI ventures. Investors should carefully consider the following:

  • Concrete implementation plan for the AI business and synergy with MDS Tech
  • Improvement in financial performance and a sustainable profitability strategy
  • Risk management and response strategy for external environmental changes